Patents Assigned to CENTRO DE INMUNOLGIA MOLECULAR
  • Monoclonal antibody and a method thereof
    Patent number: 9217037
    Abstract: The present invention relates to a humanized IgG1 isotype anti-CD6 antibody (T1h) that binds to the Scavenger receptor cysteine-rich (SRCR) domain 1 (D1) of CD6 present on the surface of thymic epithelial cells, monocytes, activated T cells and a variety of other cells types.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: December 22, 2015
    Assignees: BIOCON LIMITED, CENTRO DE INMUNOLGIA MOLECULAR
    Inventors: Ramakrishnan Melarkode, Pradip Nair, Sundaraj David Rajkumar, Kedarnath Nanjund Sastry, Monalisa Chatterji, Laxmi Adhikary, Hema Balasubramanian, Jose Enrique Montero Casimiro, Josefa Lombardero Valladares, Rolando Perez Rodriguez
  • PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-CD6 MONOCLONAL ANTIBODY USED IN THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS
    Publication number: 20100092423
    Abstract: The present invention is related to the branch of immunology and particularly with the generation of pharmaceutical compositions containing a humanized monoclonal antibody recognizing the leukocyte differentiation antigen CD6. Accordingly with that statement, the purpose of this invention is to provide pharmaceutical compositions which contain a humanized anti-CD6 monoclonal antibody for the diagnosis and treatment of Autoimmune Diseases, particularly the Rheumatoid Arthritis.
    Type: Application
    Filed: December 24, 2007
    Publication date: April 15, 2010
    Applicant: CENTRO DE INMUNOLGÍA MOLECULAR
    Inventors: Jose Enrique Montero Casimiro, Angel Raimundo Casaco Parada, Zaima Mazorra Herrera, Ruby Alonao Ramirez, Rolando Perez Rodriguez